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Abstract
Despite major attempts to prevent cholera transmission, millions of people worldwide still must address this devastating
disease. Cholera research has so far mainly focused on the causative agent, the bacterium Vibrio cholerae, or on disease
treatment, but rarely were results from both fields interconnected. Indeed, the treatment of this severe diarrheal disease is
mostly accomplished by oral rehydration therapy (ORT), whereby water and electrolytes are replenished. Commonly
distributed oral rehydration salts also contain glucose. Here, we analyzed the effects of glucose and alternative carbon
sources on the production of virulence determinants in the causative agent of cholera, the bacterium Vibrio cholerae during
in vitro experimentation. We demonstrate that virulence gene expression and the production of cholera toxin are enhanced
in the presence of glucose or similarly transported sugars in a ToxR-, TcpP- and ToxT-dependent manner. The virulence
genes were significantly less expressed if alternative non-PTS carbon sources, including rice-based starch, were utilized.
Notably, even though glucose-based ORT is commonly used, field studies indicated that rice-based ORT performs better. We
therefore used a spatially explicit epidemiological model to demonstrate that the better performing rice-based ORT could
have a significant impact on epidemic progression based on the recent outbreak of cholera in Haiti. Our results strongly
support a change of carbon source for the treatment of cholera, especially in epidemic settings.
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Introduction
The diarrheal disease cholera remains a major problem in
developing countries. In 2012, almost 250’000 cases were reported
to the WHO; however estimated numbers, including non-reported
cases, are argued to reach several million cases every year. The
recent disease outbreak in Haiti demonstrated the devastating
effects of cholera epidemics. Because of these dramatic conse-
quences, the problem of how to stop an epidemic at an early stage,
or at least to slow it down, was addressed and the employment of
general intervention strategies was discussed. In this context,
mathematical models were developed and used to predict the
outcome of major interventions, such as vaccination or extended
use of antibiotics and sanitation [1–6]. Remarkably, more general
treatment strategies have not been considered. This fact appears
surprising because, without treatment, the case fatality rate for
severe cholera is approximately 50%; however, if handled
properly, nearly all deaths can be avoided. The general treatment
of cholera patients is based on a so-called oral rehydration therapy
(ORT), which is a cost-effective and easily applicable method to
replace lost fluids and electrolytes. For the latter purpose, the
administered solution contains a mixture of several compounds
that were designated oral rehydration salts (ORS), including
sodium, chloride, and potassium ions as well as glucose. Indeed,
glucose is the most commonly added carbohydrate because it
stimulates sodium and therefore, water absorption in the small
intestine [7]. However, in field studies, it was shown that ORT
might be improved by the substitution of the carbon source (or
through the addition of amino acids and supplementation with
trace elements) [8]. The molecular mechanisms underlying these
findings remain to be resolved. Moreover, a meta-analysis
comparing the treatment with standard, glucose-based versus
rice-based ORS illustrated the beneficial effects of the latter
composition, such as reduced episodes of vomiting, a decrease of
the stool volume, and a shortened recovery time [9–12].
The aim of this study was to unravel the molecular mechanisms
underlying the better performance of rice-based treatments
(Fig. 1). To do so, we analyzed the virulence gene expression of
PLOS Neglected Tropical Diseases | www.plosntds.org 1 December 2014 | Volume 8 | Issue 12 | e3347
the causative agent of cholera, specifically the bacterium Vibrio
cholerae, when cultured under conditions resembling ORT. Our
results show that, in the presence of glucose, virulence-associated
genes were induced and cholera toxin was produced and this in
vitro induction was dependent on the main virulence regulatory
proteins ToxR, TcpP and ToxT [13]. However, substituting
glucose in ORT by an alternative non-PTS carbon source, such as
rice-derived starch, led to the significantly reduced expression of
virulence determinants in V. cholerae, which would have beneficial
effects on disease progression. Based on this evidence, the impact
of such optimized treatment on the outcome of cholera epidemics
was simulated using a mathematical model, which recapitulates
the recent Haitian cholera outbreak [4]. Our results indicate that
rice-based treatment could have significantly reduced the burden
imposed on the Haitian population.
Materials and Methods
Bacterial strains, media and growth conditions
The Vibrio cholerae strains that were used in this study are El
Tor Inaba strain A1552 [14], El Tor Inaba strain N16961 [15],
classical Ogawa strain O395 (India, 1964) [16], and derivatives of
those strains (see Supporting Table S1). All strains belong to
serogroup O1. V. cholerae strains were grown as overnight cultures
in Luria broth (LB) or M9 minimal medium at 30uC under
shaking conditions. Antibiotics were added at the following
concentrations when required: kanamycin at 75 mg/ml or
ampicillin at 100 mg/ml.
Construction of V. cholerae genetically-modified strains
The genes toxR, ptsG, and nagE were deleted from the parental
V. cholerae strain (A1552) using the TransFLP gene disruption
method [17–19], which is based on natural transformation and
FLP recombination. The same method was applied to introduce a
functional hapR gene into strain N16961 to acquire strain
N16961rep (the natural transformation was performed in the
presence of a hapR-complementing plasmid). To delete the genes
tcpP and toxT from the parental strain A1552, a gene-disruption
method based on the counter-selectable plasmid pGP704-Sac28
[20] was used. The oligonucleotide sequences that were used to
construct the transforming PCR fragments or plasmids pGP704-
28-SacB-DVC0826 and pGP704Sac28DtoxT-II are indicated in
Supporting Table S2. Genomic DNA from V. cholerae strain
A1552 served as a template.
In vitro induction of virulence gene expression
A detailed protocol for virulence gene expression in V. cholerae
is provided in the Supporting Information (Supporting Text S1).
Briefly, bacteria were grown in a M9 minimal salt medium
(Sigma-Aldrich, Buchs, Switzerland), which contained vitamins
and casamino acids, as well as the carbon source of interest.
Virulence gene expression was induced by the addition of sodium
bicarbonate (Fluka, St. Louis, USA) as published for rich medium
conditions [21]. Gene expression was evaluated using quantitative
reverse transcription-based PCR (qRT-PCR) as described [22].
The gene-specific primers that were used for qRT-PCR are
indicated in Supporting Table S2.
Enzyme-linked immunosorbent assay (ELISA)
Cholera toxin (CT) concentrations were determined using a
CT-ELISA, which was performed essentially as reported [23],
Figure 1. Glucose-based oral rehydration therapy (ORT) might
enhance the production of virulence determinates in V.
cholerae thereby extending the duration of the disease and
worsen the symptoms compared to rice-based ORT. Upon
virulence-inducing conditions (e.g., in the human intestine or by in vitro
provision of bicarbonate as inducer [21,29]) the human pathogen V.
cholerae expresses amongst others the virulence genes of the tcp and
ctx clusters, which ultimately leads to the synthesis and assembly of the
toxin-coregulated pilus (TCP) and the production of cholera toxin,
respectively. The TCP forms a type IV pilus structure on the bacterial
surface, which is required for intestinal colonization. The cholera toxin
indirectly leads to efflux of ions (concomitantly with water), which
causes the dramatic watery diarrhea, the hallmark of cholera. In this
study, we assessed the expression of the tcp and ctx genes and the
production of cholera toxin under virulence-inducing conditions and in
the presence of diverse carbon sources. Our data indicate that glucose
strongly enhances the virulence potential of the pathogen (indicated by
the arrows). Thus, based on the better performance of rice-based ORT
as described in field studies and on our model-guided prediction of
cholera transmission under epidemic settings we suggest that rice-
based ORT should be reconsidered for the treatment of cholera.
doi:10.1371/journal.pntd.0003347.g001
Author Summary
Cholera research has so far mainly focused on the
causative agent, the bacterium Vibrio cholerae, or on
disease treatment, but rarely were results from both fields
interconnected. Indeed, the treatment of this severe
diarrheal disease is mostly accomplished by oral rehydra-
tion therapy (ORT). ORT aims at rehydrating patients
through the provision of water and oral rehydration salts;
the latter being composed of electrolytes as well as
glucose as a carbon source. Although glucose-based ORS
is commonly used to treat diarrheal diseases and is
recommended by the WHO, field studies on cholera
indicated that rice-based ORT performs better than
glucose-based ORT. Here, we investigated the impact that
glucose, starch, or other carbon sources exert on V.
cholerae. We demonstrated that glucose leads to an
increased expression of the major virulence genes in the
pathogen and, accordingly, to an enhanced production of
cholera toxin during in vitro experimentation. Because the
cholera toxin is primarily responsible for the severe
symptoms that are associated with the disease, our study
highlights the negative effects of glucose-based ORT. Next,
we used a spatially explicit epidemiological model to
demonstrate that the better performing rice-based ORS
could have a significant impact on epidemic progression
based on the recent outbreak of cholera in Haiti.
Glucose-Based ORS Extends the Duration of Cholera
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with the exception that phosphate-citrate buffer containing sodium
perborate was used for detection.
Mathematical model of the cholera epidemic in Haiti
A mathematical model was applied to recapitulate the first year
of the cholera outbreak that recently occurred in Haiti and to
estimate the potential impact of rice-based ORT. In addition to
the epidemiological processes that are relevant to cholera
transmission, the model also takes hydrological pathogen trans-
port, human mobility, and precipitation into account (see
Supporting Text S1). Model parameters were estimated based
on the available literature or calibrated using a Bayesian approach.
The modeled progression of the cholera epidemic corresponded
well with the observed cases (details on the spatial match of
reported cases and simulation results are provided elsewhere
[4,6,24,25]; see also Supporting Text S1). Next, the described
effects of the rice-based treatment were implemented. This is
compared with standard glucose-based ORS by assuming that (a)
during the actual course of the Haiti epidemic all symptomatic
infected people received a glucose-based ORT, and (b) all
parameters (namely patterns of human mobility, demography,
bacterial ecology, and exposure rates) are assumed unaltered by
the ORT except for the shedding rate and disease duration
(according to [9–12]). Moreover, a 30-days lag period between the
initial cholera case and the switch to the rice-based ORT was
included because this timeframe seems reasonable to first confirm
the causative agent of the diarrheal disease outbreak as being V.
cholerae at the onset of the epidemic. Details regarding the model
structure, the parameterization, and the validation can be found in
the Supporting Information, which contains Supporting Text S1,
Supporting Figures (Fig. S3, Fig. S4, Fig. S5, Fig. S6, and Fig. S7)
and Supporting Tables (Table S4 and Table S5).
Results
Induction of virulence gene expression in V. cholerae in
the presence and absence of glucose
This study aimed to investigate how different carbon sources
that are used for cholera treatment influence the production of the
major virulence determinants in V. cholerae, cholera toxin (CT)
and the toxin-coregulated pilus (TCP)(Fig. 1). CT is an AB5-toxin,
which consists of two different subunits that are encoded by the
genes ctxA and ctxB. Whereas the B subunit is important for the
binding to host cells, the A subunit indirectly activates the enzyme
adenylate cyclase within gut epithelial cells, which leads to an
increased secretion of chloride and concomitantly increased
secretion of water (Fig. 1). CT alone can cause diarrhea, and the
amount of CT intake was shown to be proportional to the severity
of symptoms [26,27]. The second major virulence factor of
pathogenic V. cholerae strains, TCP, is important for intestinal
colonization [28]. The pilus structure primarily consists of the
major pilin TcpA, whereas the residual tcp gene products are
important for the pilus structure and for its assembly (Fig. 1).
We first established an assay to monitor the expression of these
major virulence genes when the bacteria were grown under
conditions that somewhat mimic those conditions that are
encountered in patients undergoing ORT. To this extent, we
used a bicarbonate-mediated in vitro virulence induction protocol
[21,29] but changed the culture medium to minimal salts
(resembling ORS) instead of the previously described rich-medium
conditions. Using quantitative qRT-PCR, we demonstrated that,
upon growth of the V. cholerae wild-type O1 El Tor strain (A1552)
in the presence of glucose, the genes ctxA, ctxB, tcpA and tcpB
were significantly induced whereas significantly lower induction
was observable when lactate was used as alternative carbon source
(Fig. 2A) or under virulence-non-inducing conditions (Fig. S1 and
Table S3). To confirm that the reduced virulence gene expression
is also reflected in reduced protein levels of the virulence
determinants, we analyzed the accumulation of CT in culture
supernatants using an ELISA. Indeed, the amount of cholera toxin
decreased to,25% for cultures that were grown in the presence of
lactate compared with glucose (Fig. 2B).
Because it has become evident in recent years that the
regulation of virulence genes differs between diverse pathogenic
isolates [30,31], we applied our method to two other epidemic V.
cholerae strains. N16961 is an El Tor O1 strain (as is strain
A1552), whereas O395 is a classical O1 biotype strain [15,16].
Indeed, these two strains also exhibited a glucose-dependent
induction of virulence genes (Fig. S1), which indicates the general
impact of carbon sources on the regulatory network of virulence-
associated genes in V. cholerae.
Effect of diverse carbon sources on virulence gene
expression
Most bacteria transport preferred sugars, such as glucose, by so-
called phosphoenolpyruvate-phosphotransferase systems (PTS);
therefore, the corresponding carbohydrates are often denoted as
PTS sugars. During the sugar uptake via the PTS, a phosphoryl
group is transferred onto the imported sugar, which prepares the
sugar for central metabolism. In contrast, the enzyme adenylate
cyclase, which is responsible for the production of the secondary
Figure 2. Expression and production of virulence factors in V.
cholerae is enhanced in the presence of glucose. (A) Relative
expression of virulence-associated genes in the V. cholerae wild-type
strain A1552. The virulence inducer bicarbonate was present in all
samples. Supplemented carbon sources were lactate and glucose as
indicated by the white and black columns, respectively. Statistics were
applied using Student’s t-test (**, P#0.01; ***, P#0.001). (B) Quantifi-
cation of cholera toxin that was produced upon growth on diverse
carbon sources (as indicated). The data were normalized by the OD600
values of the bacterial culture. For rice starch-grown cells the OD600
value was deduced from the number of counted bacteria. All data
represent averages from three independent biological experiments 6
SD.
doi:10.1371/journal.pntd.0003347.g002
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messenger cyclic AMP (cAMP), is activated when cells run short of
PTS sugars. cAMP that is bound to the cAMP-receptor protein
(CRP) is a crucial signaling compound and modulates several
processes in bacteria [32]. Thus, we asked the question whether
the observed virulence induction was specific to glucose, specific to
PTS sugars, or a broader effect that was exerted by many carbon
sources. Therefore, we tested other PTS sugars in addition to
glucose (e.g., N-acetylglucosamine and sucrose) and observed a
comparable induction of the virulence genes, as demonstrated for
glucose (Tables 1 and 2). In contrast, galactose and succinate,
which are two non-PTS carbon sources, led to highly reduced
virulence expression (Table 1). More importantly, we demonstrat-
ed that V. cholerae induces the virulence determinants at
significantly lower levels when starch was provided as the sole
carbon source, which mimics the conditions of rice-based ORT
(Table 1). This reduced virulence gene expression was again
reflected in the accumulation of CT, which decreased to 10–25%
for cultures that were grown in the presence of non-PTS carbon
sources (e.g., lactate, galactose, succinate or starch) compared with
glucose (Fig. 2B).
Sugar transport is crucial for the induction of the
virulence genes
To elucidate whether the sugar-dependent virulence induction
is linked to the transport of the PTS sugars we employed
genetically modified V. cholerae strains, which lacked the PTS
transporters for glucose, N-acetylglucosamine, or sucrose. In these
strains, the signaling pathway that was described above is
disrupted, thereby allowing cAMP to accumulate in the bacterial
cell. As shown in Table 2, the increase of virulence gene
expression upon provision of the inducer bicarbonate was
abolished in those strains, which were cultivated in the presence
of the corresponding PTS sugars (with the concomitant addition of
lactate to maintain growth). Therefore, we conclude that the
expression of the virulence genes is not dependent on any
particular sugar per se but is dependent on the PTS-coupled
regulatory circuit.
Role of quorum sensing and the regulatory protein HapR
The PTS-dependent signaling pathway (including the sec-
ondary messenger cAMP) is part of a process known as carbon
catabolite repression in bacteria [32]. This mechanism allows
bacteria to first utilize preferred sugars through the repression
of uptake complexes and catabolic enzymes that are required
for the utilization of less-preferred carbon sources. Earlier
studies have indicated that carbon catabolite repression also
acts as a modulator of quorum sensing (QS) in V. cholerae [33].
QS is commonly used by bacteria to assess population densities
and to respond appropriately to these [34]. The master
regulator of QS in V. cholerae is the protein HapR, which is
produced at high cell density and which represses the virulence
genes [35,36]. Consistent with these earlier studies, we observed
increased virulence gene expression in a hapR mutant strain
when compared with the wild-type strain (Fig. S2). Further-
more, the V. cholerae strain N16961 [15], which has a
frameshift mutation in hapR that renders the HapR protein
non-functional [35], also showed increased virulence gene
expression compared with a genetically modified variant of
N16961 in which the hapR gene was repaired (Fig. S2).
However, the hapR mutant strain still displayed glucose-
responsiveness with respect to virulence gene expression, which
indicated that carbon catabolite repression also influences
virulence in a QS-independent manner (Fig. S2).
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In vitro virulence-inducing conditions reflect the in vivo
situation
As the aforementioned observations were based on in vitro data
the question arose as to how these data compare to the situation
within human patients. It should be noted that field studies
indicated that rice-based (e.g., starch-based) ORT performs better
compared to standard glucose-based ORT though the underlying
mechanism remained elusive [9–12]. Apart from these important
field study data it is difficult or even impossible to test the in vivo
situation under laboratory conditions (e.g., outside the human
intestine). The reason for that is that animal models do not
recapitulate the disease well. Indeed, both adult rabbits and adult
mice are naturally resistant to infection with the pathogen. Thus,
the most prominent animal models of cholera are the rabbit ileal
loop model and the infant mice model (for recent review see [37]).
The first model primarily reflects the enterotoxicity of the bacteria
measured by the accumulation of fluid within ligated intestinal
loops. However, this model does not take the natural oral infection
route into consideration (e.g., external cues encountered through-
out the gastrointestinal passage). Moreover, due to the feature of
the model as being a closed system it does not allow any ORT
treatment studies. Lately, infant mice (suckling mice) have been
widely used to study virulence factors of V. cholerae. The infant
mice model allows elucidating the potential of the pathogen to
grow inside the animal and to colonize the small intestine.
However, infant mice do not develop severe diarrhea and fluid
replacement by ORT is therefore impossible. Notably, these
models have been extremely valuable for deciphering the
pathogenicity of the bacterial pathogen [37]. For example the
involvement of TCP in intestinal colonization was established
based on the suckling mice model [28](Fig. 1), which was later
confirmed to also be relevant in humans based on volunteer
studies [38]. We therefore reasoned that the relevance of our in
vitro data would be significantly strengthened if we could confirm
that the observed in vitro virulence expression would still be
subject to the well-established regulatory cascade of virulence
induction in V. cholerae (‘‘the ToxR regulon’’ [39]), which
includes the main regulatory proteins TcpP, ToxR [28,40], and
ToxT [41] (for review see [13,42])(Fig. 3A).
To this extent, we first generated V. cholerae knockout strains
lacking either toxR or tcpP (Fig. 3A; Supporting Table 1) and
subjected these strains and the parental wild-type strain to in vitro
virulence induction in the presence of different carbon sources.
Importantly, we saw a strong and statistically significant decrease
in the expression of all tested virulence genes (tcpA, tcpB, ctxA,
ctxB) in the presence of glucose when TcpP and ToxR were absent
(Fig. 3B). As both of these regulatory proteins are required for the
production of ToxT (Fig. 3A), the master regulator of virulence,
which directly activates the tcp and ctx gene cluster by binding to
so called toxboxes [13], we next tested the contribution of ToxT to
virulence induction under the here described in vitro virulence
induction conditions. Indeed, the expression of toxT under
virulence-inducing conditions was significantly increased in the
presence of glucose compared to lactate (Fig. 2A) and this increase
was dependent on the presence of the respective PTS transport
system (Table 2). Importantly, when we deleted the toxT gene or
grew the wild-type cells in the presence of the ToxT inhibitor
virstatin [43,44] the glucose-dependent virulence induction was
absent or significantly reduced (Figs. 3C and 3D) highlighting the
importance of ToxT for in vitro virulence induction. Thus, as the
in vitro induction of virulence determinants was dependent on the
main regulatory proteins TcpP, ToxR, and ToxT we concluded
that our approach recapitulates the in vivo situation to a certain
extent and that the here described glucose-dependent expression
Table 2. PTS sugar-dependent virulence gene expression requires sugar uptake.
tested gene WT (2) WT (+) Dpts (2) Dpts (+) fold difference WT (+)/Dpts (+) statistics
glucose
tcpA 16.9 (61.5) 114.8 (66.6) 14.5 (67.7) 17.7 (66.8) 6.5 ***
tcpB 7.1 (61.2) 59.9 (68.0) 6.6 (61.9) 9.2 (63.6) 6.5 **
ctxA 21.5 (63.2) 83.3 (618.2) 19.8 (67.6) 20.2 (69.1) 4.1 *
ctxB 7.5 (60.6) 28.7 (63.6) 5.9 (62.2) 6.4 (62.5) 4.5 **
toxT 5.0 (61.2) 11.5 (63.4) 2.9 (60.3) 2.2 (60.5) 5.3 *
GlcNAc
tcpA 12.8 (62.0) 123.5 (617.2) 8.4 (62.9) 3.9 (62.9) 31.3 **
tcpB 6.5 (61.4) 65.6 (67.9) 3.9 (60.7) 2.5 (60.7) 26.0 **
ctxA 18.9 (67.0) 99.9 (623.5) 17.4 (65.9) 14.6 (65.3) 6.8 *
ctxB 6.8 (62.3) 30.6 (64.7) 5.6 (61.6) 4.9 (62.0) 6.2 **
toxT 4.5 (60.9) 9.6 (63.9) 2.3 (60.6) 1.6 (60.1) 6.1 ns
sucrose
tcpA 11.5 (62.5) 91.9 (617.1) 2.4 (60.8) 3.3 (61.7) 27.4 *
tcpB 5.8 (60.4) 49.2 (67.3) 2.2 (60.2) 2.8 (60.4) 17.7 **
ctxA 15.4 (65.6) 69.0 (611.0) 8.1 (61.9) 12.4 (67.1) 5.6 **
ctxB 5.0 (61.7) 22.4 (62.1) 2.4 (60.6) 4.2 (62.8) 5.3 **
toxT 3.7 (60.7) 8.4 (64.4) 1.4 (60.1) 2.1 (60.9) 4.1 ns
Bacterial cultures contained the indicated carbon sources (glucose, GlcNAc, sucrose) plus lactate to maintain growth. Strains tested for the expression of the indicated
genes (relative to the housekeeping gene gyrA) were: wild-type (WT), and the respective PTS mutants for glucose (DptsG), GlcNAc (DnagE), and sucrose (DscrA) in the
absence (2) or presence (+) of bicarbonate as virulence inducer. Average of at least three independent experiments (6 SD) are depicted. Statistics were applied using
Student’s t-test comparing the WT (+) and Dpts (+) conditions (* P#0.05; ** P#0.01; *** P#0.001; ns, not statistically different).
doi:10.1371/journal.pntd.0003347.t002
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of the main pathogenicity genes most likely also occurs in human
patients. This finding would be consistent with the increased
disease burden associated with glucose-based ORT compared to
rice-based ORT [9–12].
Starch as an alternative carbon source in ORT
Because we demonstrated above that starch does not support
virulence gene expression to the same high level as glucose does,
we aimed to test whether virulence could still be lowered by starch
if previously induced. Indeed, such a scenario would occur at the
onset of cholera symptoms and upon initial treatment with
glucose-based ORS. Thus, we grew V. cholerae in glucose-
containing virulence-inducing medium for a short period before
washing the bacteria and shifting them to fresh medium, which
contained either glucose or starch. Using this experimental
approach, we observed a significantly reduced amount of CT
(down to ,25%) in starch-shifted cultures compared with the
glucose-grown bacteria (Fig. 4). These data suggest that the
administration of rice-based ORS, even after the initial virulence
induction, would still significantly reduce CT accumulation along
with reduced cholera symptoms.
Figure 3. Expression of virulence determinants is dependent on the common virulence regulators under in vitro conditions. (A)
Simplified overview of the regulatory cascade that is involved in virulence gene expression in V. cholerae. toxT expression occurs upon activation by
the regulatory proteins ToxR and TcpP (complexed with ToxS and TcpH, respectively) as indicated by the arrows (solid lines). Next, the synthesized
ToxT protein (dashed arrow) induces the expression of the tcp cluster and the ctxAB operon, which ultimately leads to the production of TCP and CT.
Elements acting upstream tcpPH and toxRS are excluded for sake of simplicity. Scheme is based on [13]. (B+C) Relative expression of the genes tcpA,
tcpB, ctxA, and ctxB in diverse V. cholerae strains, which were grown under virulence-inducing conditions in the presence of lactate (lac) or glucose
(glc). Strains tested as indicated above the graphs: panel B: wild type V. cholerae strain (WT; A1552-TntfoX) and its toxR and tcpP-negative derivatives
(DtoxR and DtcpP). panel C: wild type (WT; A1552) and DtoxT (A1552DtoxT). (D) As in panels B and C except that the V. cholerae wild-type strain was
grown under glucose-containing virulence-inducing conditions in the presence of DMSO (gray bars) or virstatin (50 mM dissolved in DMSO; red bars).
The values shown in panels B, C, and D represent averages of at least three independent biological replicates (6 SD) Statistics were applied on
pairwise comparisons using Student’s t-test (ns, non-significant; *, P#0.05; **, P#0.01; ***, P#0.001).
doi:10.1371/journal.pntd.0003347.g003
Figure 4. Shifting V. cholerae from glucose-based to starch-
based conditions leads to a decrease in CT production. Bacterial
cultures were induced for virulence in the presence of glucose for
30 min, washed (where indicated) and shifted to virulence-non-
inducing or virulence-inducing medium containing either glucose or
starch. The amount of CT was determined as described for Figure 2.
Statistically significant differences were determined through Student’s
t-test (* P#0.05).
doi:10.1371/journal.pntd.0003347.g004
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Modeling the impact of rice-based ORS on the Haitian
cholera epidemic
The data that were presented above provide a molecular
explanation for why rice-based ORS performed better in field
studies [9–12]. However, one wonders whether disease shortenings
and reduced stool output, as described for rice-based ORT, would
have any impact on large-scale patterns of cholera epidemics. We
therefore used a spatially explicit epidemiological model [1,4,6] to
recapitulate the recent Haitian cholera outbreak. The model
consists of 365 nodes (human communities) that are spread over
the Haitian territory (Fig. 5A).
Quantifying the reduction of shedding rate and disease duration
is not easy. Our in vitro experiments suggest a strong reduction of
the amount of CT, which matches the observed reduction of
shedding rates from field studies [9–12]. This reduction can be as
high as 50% (especially compared to the glucose-based ORS,
which was recommended by the WHO before 2002 (WHO-ORS);
see discussion). Reduction of diarrhea duration is smaller and
usually no larger than 30%. If one assumes a 10% reduction in
both duration and shedding rate for rice-based compared with
glucose-based ORT (for HYPO-ORS; [12]), the model predicts a
considerable decrease in disease incidence over the entire country
(Fig. 5B). Indeed the total number of cholera cases within the first
14 months of the epidemic would be reduced from 520,000 cases
(as reported by the Haitian Ministry of Health and available online
at http://mspp.gouv.ht; our model predicts 535,000 cases) to
375,000 cases (i.e. 30% [22%–39%] less total cases until the end of
2011) according to the model. More importantly, if these
parameters could be reduced by 15%, then the total number of
cholera cases would drop by 59% [47%–67%], and if the
parameters were reduced by 20%, the number of cases would even
decrease by 74% [71%–76%] (Fig. 5C). The ranges of variation
shown reflect the 2.5th–97.5th percentiles of the uncertainty related
to parameter estimation. Such behavior (i.e. the more than
doubled reduction of total infections owing to a 10% to 20%
reduction in bacterial shedding and disease duration) is typical of
nonlinear epidemiological models [6]. Interestingly, owing to a
higher number of susceptibles (Fig. S7 and Supporting Text S1), a
larger number of cholera cases would have been predicted for
November 2011, one year after the initial onset of the outbreak,
most probably triggered by important rainfall events, which have
been shown to play a major role in the dynamics of the epidemic
[4,45]. However, such a one-year time span would have allowed
other intervention strategies to be put into place, which could
potentially avoid later cholera case peaks e.g., by reducing
exposure rates via improved water sanitation.
Discussion
Cholera remains a major social emergency in developing
countries and despite major research efforts this disease is far from
being eradicated. Here, we aimed at understanding why an
alternative cholera treatment, which relies on rice-based instead of
glucose-based ORS, has beneficial effects on disease outcome as
reported in field studies (Fig. 1). For this purpose, we tested the
expression of virulence-associated genes in V. cholerae using
defined virulence-inducing minimal medium conditions and a
variety of carbon sources. Using this approach, we demonstrated
that the virulence genes were upregulated in different clinical
isolates of V. cholerae as long as those strains were grown in the
presence of glucose or other PTS sugars (Fig. 2A, Fig. S1 and
Table 1). The amount of cholera toxin produced under these
conditions reflected the expression data (Fig. 2B). Because the
cholera toxin is primarily responsible for the severe symptoms that
are associated with the disease, our study highlights the negative
effects of glucose-based ORT. Interestingly, in 2002, the WHO
announced the recommendation to reduce the osmolarity in ORS
[46]. Concomitantly, the final concentration of glucose was
Figure 5. Modeling the effect of rice-based ORT on the Haitian
cholera outbreak. (A) Computational subunits of Haiti with population
sizes. Each unit corresponds to one node in our model. (B) Evolution of
the epidemic over time for the entire country. Observed cases (grey bars),
calibrated model (dark blue), and model runs with a ten percent
reduction of symptomatic shedding rate as well as disease duration due
to rice-based ORT (light blue). Shaded areas show the 95% confidence
intervals resulting from parameter uncertainty; the solid lines show the
median trajectory. The replacement of glucose-based with rice-based
ORT was assumed to take place 30 days after the onset of the epidemic.
(C) Evolution of the epidemics based on shedding rate and disease
duration. Contour plot of the percentage of total cases in the whole
country until December 2011, predicted by the model when applying
variable reductions of the shedding rate (y-axis) and disease duration (x-
axis), compared to the cases predicted by the calibrated model.
doi:10.1371/journal.pntd.0003347.g005
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lowered from the initial 111 mM (WHO-ORS) to 75 mM
(HYPO- ORS). Nevertheless, we observed that lowering the
concentration of glucose in this range (from 111 mM glucose that
was previously used, toward the 75 mM current recommendation,
or even down to 50 mM, such as in our assays, because this
concentration might better reflect the concentration within the
intestine) did not reduce virulence gene expression in V. cholerae
(Table 1). To our knowledge, this study is the first to describe the
PTS sugar-dependent expression of virulence genes in V. cholerae
cells grown in minimal salt conditions, although a putative cAMP-
CRP binding site in the tcpA promoter region has been proposed
previously [47] and the repression of TCP and CT by cAMP-CRP
has been described [48]. Furthermore, a link between carbon
catabolite repression and QS-dependent virulence repression has
been reported before [33,35,49]; however, our data indicate that
PTS-sugars also influence virulence expression in a QS-indepen-
dent manner (Fig. S2), which might be due to the binding of the
cAMP-CRP complex to the putative cAMP-CRP binding site [47]
mentioned above.
In summary, our findings indicate that the virulence cascade of
V. cholerae is inducible only in the presence of PTS sugars.
Concomitantly, cholera toxin is produced on a larger scale when
glucose is provided, which is a situation that most likely occurs
when patients undergo standard glucose-based ORT. No such
increase in CT production and virulence gene expression was
observed when starch was used as alternative carbon source, which
mimics rice-based ORT. Moreover, a switch from a glucose-based
to a starch-based medium still resulted in decreased virulence gene
expression in V. cholerae, which indicated that rice-based ORS
would still be beneficial even if rice-based ORS were applied after
the onset of symptoms. These results are supported by clinical
studies, which demonstrated that rice-based ORS performed
better in the field than standard glucose-based ORS [9–12]. The
implementation of rice-based ORT has important effects on the
epidemiological course of cholera. Indeed, the results of our model
study of the Haitian cholera epidemic indicated a significant
reduction in the total number of cholera cases using the range of
parameters published for rice-based ORS. Notably, this significant
reduction in cholera cases might even be an underestimation given
that rice-based ORT might effectively down-regulate virulence
gene expression in the pathogen thereby abolishing the hyper-
infectivity state that has been described for V. cholerae [21,50].
This would ultimately lead to an even lower transmission rate
within the population. However, current recommendations by the
WHO do not fully support the use of rice-based ORS for reasons
such as product stability, increased packaging size, mode of
application, and a three-fold cost over glucose-based ORS ($0.20
per liter of final ORS solution compared with $0.07) [51]. On the
other hand, recent improvements in the food/nutrition industry
might have optimized those handling- and cost-associated issues of
starch-based products. Due to the described beneficial effects of
rice-based ORS, the molecular explanations provided in this
study, and the impact that those beneficial effects could have on
epidemic progression, we recommend reconsidering starch-based
ORS for cholera treatment.
Supporting Information
Figure S1 Relative expression of virulence-associated
genes in indicated V. cholerae strains. Virulence-expression
was assessed in diverse V. cholerae isolates (A, O1 El Tor strain
A1552; B, O1 El Tor strain N16961; C, O1 classical strain O395).
Bacteria were grown with the indicated carbon sources and under
virulence-non-inducing (2) and virulence-inducing (+) conditions.
Different oligonucleotides were used for the amplification of El
Tor-type tcpA or classical type tcpA (see Supporting Table S3).
Statistics were applied using Student’s t-test (* P#0.05, ** P#
0.01, *** P#0.001). All data represent averages from three
independent biological replicates 6 SD.
(PDF)
Figure S2 Quorum sensing (QS)-dependent and QS-
independent virulence gene expression. (A) Comparison of
virulence gene expression in QS-capable and QS-defective strains
of V. cholerae. All strains were grown in the presence of the
virulence inducer bicarbonate and glucose. (B) Virulence gene
expression in the QS-defective strain DhapR that was grown with
lactate or glucose as indicated. For expression details, see the
legend of Supporting Fig. S1.
(PDF)
Figure S3 Schematic representation of the model. Si
stands for susceptible individuals at node i, IS,i and IA,i for
symptomatically and asymptomatically infected, respectively, Ri
for recovered and Bi for bacterial concentration. Blue and red
solid arrows indicate fluxes of individuals and bacteria, respec-
tively, whereas the red dashed arrow indicates that the bacterial
concentration governs the infection. Small blue forth and back
arrows stand for human mobility between nodes and small red
ones for hydrological V. cholerae transport. The single small blue
arrow represents mortality due to cholera. Natural mortality is not
shown.
(PDF)
Figure S4 Evolution of the epidemics in Haiti per
department. Observed cases (grey bars), calibrated model (dark
blue), and model runs with a ten percent reduction of symptomatic
shedding rate as well as disease duration due to rice-based ORT
(light blue). Shaded areas show the 95% confidence intervals
resulting from parameter uncertainty; the solid lines show the
median trajectory. The replacement of glucose-based with rice-
based ORT was assumed to take place 30 days after the onset of
the epidemic. Departments are (from left to right, top to bottom):
Artibonite, Centre, Grande Anse, Nippes, Nord, Nord-Est, Nord-
Ouest, Ouest, Sud, and Sud-Est. Daily rainfall in each department
is also shown (top of each panel).
(PDF)
Figure S5 Total cases through December 2011. The data
are based on the model, which was calibrated with different values
of qA/qS (dark blue). Light blue bars show model runs using the
exact same parameters except for the addition of a ten percent
decrease of shedding rate and a ten percent shortening of the
disease duration (see Supporting Text S1 for discussion).
(PDF)
Figure S6 Evolution of the epidemics. Observed cases (grey
bars) and model calibrated with a range of different values for qA/
qS (blue lines, see Supporting Fig. S5).
(PDF)
Figure S7 Evolution of modeled susceptibles and symp-
tomatic infected. The solid lines show the modeled evolution of
the number of total susceptibles over time as calibrated (dark blue)
and with a 10% reduction in bacterial shedding rate as well as
disease duration (light blue). Dashed lines: idem for the number of
symptomatic infected. Trajectories shown correspond to the best
performing parameter set. Note the higher number of susceptibles
in fall 2011 after introducing the reductions, which leads to the
more pronounced peak of total infections in November 2011.
(PDF)
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Table S1 V. cholerae strains used in this study.
(DOCX)
Table S2 Oligonucleotides used in this study.
(DOCX)
Table S3 Virulence gene expression under virulence-
non-inducing (2) or virulence-inducing (+) conditions
and in the presence of the indicated carbon sources.
(DOCX)
Table S4 Model parameters with their values and
references.
(DOCX)
Table S5 Number of calibrated parameters and AIC
scores for calibration with and without qA/qS.
(DOCX)
Text S1 Supporting methodology and results. This file
contains a description of the in vitro virulence gene expression
approach and the qRT-PCR protocol. In addition, the file
contains a description of the model and details with respect to the
calibration of the model and the estimation of parameters. The
references of all supporting methods, figures, and tables are also
included in this file.
(PDF)
Acknowledgments
The authors would like to thank all group members for fruitful discussions
on the project.
Author Contributions
Conceived and designed the experiments: JK FF EB MG AR MB.
Performed the experiments: JK FF EB SB MG ARMB. Analyzed the data:
JK FF EB MG AR MB. Initiated the project and led the study: MB.
Discussed, designed, and analyzed the experiments with respect to the
virulence gene expression and CT production: JK MB. Performed the wet-
lab experiments: JK SB MB. Designed, discussed, performed, and analyzed
the modeling approach: FF EB MG AR. Wrote the manuscript: JK MB.
Contributed to the text: FF EB MG AR.
References
1. Bertuzzo E, Mari L, Righetto L, Gatto M, Casagrandi R, et al. (2011) Prediction
of the spatial evolution and effects of control measures for the unfolding Haiti
cholera outbreak. Geophys Res Lett 38: L06403. doi:10.1029/2011GL046823.
2. Andrews JR, Basu S (2011) Transmission dynamics and control of cholera in
Haiti: an epidemic model. Lancet 377: 1248–1255.
3. Tuite AR, Tien J, Eisenberg M, Earn DJ, Ma J, et al. (2011) Cholera Epidemic
in Haiti, 2010: Using a Transmission Model to Explain Spatial Spread of
Disease and Identify Optimal Control Interventions. Ann Intern Med 154: 593–
601.
4. Rinaldo A, Bertuzzo E, Mari L, Righetto L, Blokesch M, et al. (2012)
Reassessment of the 2010–2011 Haiti cholera outbreak and rainfall-driven
multiseason projections. Proc Natl Acad Sci USA 109: 6602–6607.
5. Chao DL, Halloran ME, Longini IM, Jr. (2011) Vaccination strategies for
epidemic cholera in Haiti with implications for the developing world. Proc Natl
Acad Sci USA 108: 7081–7085.
6. Gatto M, Mari L, Bertuzzo E, Casagrandi R, Righetto L, et al. (2012)
Generalized reproduction numbers and the prediction of patterns in waterborne
disease. Proc Natl Acad Sci USA 109: 19703–19708.
7. Farthing MJ (2002) Oral rehydration: an evolving solution. J Pediatr Gastro-
enterol Nutr 34 Suppl 1: S64–67.
8. Atia AN, Buchman AL (2009) Oral rehydration solutions in non-cholera
diarrhea: a review. Am J Gastroenterol 104: 2596–2604; quiz 2605.
9. Gore SM, Fontaine O, Pierce NF (1992) Impact of rice based oral rehydration
solution on stool output and duration of diarrhoea: meta-analysis of 13 clinical
trials. BMJ 304: 287–291.
10. Molla AM, Ahmed SM, Greenough WB, 3rd (1985) Rice-based oral rehydration
solution decreases the stool volume in acute diarrhoea. Bull World Health
Organ 63: 751–756.
11. Guarino A, Albano F, Guandalini S (2001) Oral rehydration: toward a real
solution. J Pediatr Gastroenterol Nutr 33 Suppl 2: S2–S12.
12. Dutta D, Bhattacharya MK, Deb AK, Sarkar D, Chatterjee A, et al. (2000)
Evaluation of oral hypo-osmolar glucose-based and rice-based oral rehydra-
tion solutions in the treatment of cholera in children. Acta Paediatr 89: 787–
790.
13. Matson JS, Withey JH, DiRita VJ (2007) Regulatory networks controlling Vibrio
cholerae virulence gene expression. Infect Immun 75: 5542–5549.
14. Yildiz FH, Schoolnik GK (1998) Role of rpoS in stress survival and virulence of
Vibrio cholerae. J Bacteriol 180: 773–784.
15. Heidelberg JF, Eisen JA, Nelson WC, Clayton RA, Gwinn ML, et al. (2000)
DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae.
Nature 406: 477–483.
16. Kabir S (1982) Characterization of the lipopolysaccharide from Vibrio cholerae
395 (Ogawa). Infect Immun 38: 1263–1272.
17. De Souza Silva O, Blokesch M (2010) Genetic manipulation of Vibrio cholerae
by combining natural transformation with FLP recombination. Plasmid 64: 186–
195.
18. Blokesch M (2012) TransFLP – a method to genetically modify V. cholerae based
on natural transformation and FLP-recombination. J Vis Exp 68: e3761.
doi:3710.3791/3761
19. Borgeaud S, Blokesch M (2013) Overexpression of the tcp gene cluster using the
T7 RNA polymerase/promoter system and natural transformation-mediated
genetic engineering of Vibrio cholerae. PLoS One 8: e53952.
20. Meibom KL, Li XB, Nielsen AT, Wu CY, Roseman S, et al. (2004) The Vibrio
cholerae chitin utilization program. Proc Natl Acad Sci USA 101: 2524–2529.
21. Nielsen AT, Dolganov NA, Rasmussen T, Otto G, Miller MC, et al. (2010) A
bistable switch and anatomical site control Vibrio cholerae virulence gene
expression in the intestine. PLoS Pathog 6: e1001102.
22. Lo Scrudato M, Blokesch M (2012) The regulatory network of natural
competence and transformation of Vibrio cholerae. PLoS Genet 8: e1002778.
23. Gardel CL, Mekalanos JJ (1994) Regulation of cholera toxin by temperature,
pH, and osmolarity. In: Virginia L. Clark PMB, editor. Methods in Enzymology:
Academic Press. pp. 517–526.
24. Bertuzzo E, Azaele S, Maritan A, Gatto M, Rodriguez-Iturbe I, et al. (2008) On
the space-time evolution of a cholera epidemic. Water Resour Res 44: W01424.
25. Mari L, Bertuzzo E, Righetto L, Casagrandi R, Gatto M, et al. (2012) Modelling
cholera epidemics: the role of waterways, human mobility and sanitation.
J R Soc Interface 9: 376–388.
26. Burrows W, Musteikis GM (1966) Cholera infection and toxin in the rabbit ileal
loop. J Infect Dis 116: 183–190.
27. Levine MM, Kaper JB, Black RE, Clements ML (1983) New knowledge on
pathogenesis of bacterial enteric infections as applied to vaccine development.
Microbiol Rev 47: 510–550.
28. Taylor RK, Miller VL, Furlong DB, Mekalanos JJ (1987) Use of phoA gene
fusions to identify a pilus colonization factor coordinately regulated with cholera
toxin. Proc Natl Acad Sci USA 84: 2833–2837.
29. Abuaita BH, Withey JH (2009) Bicarbonate Induces Vibrio cholerae virulence
gene expression by enhancing ToxT activity. Infect Immun 77: 4111–4120.
30. Yoon SS, Mekalanos JJ (2006) 2,3-butanediol synthesis and the emergence of the
Vibrio cholerae El Tor biotype. Infect Immun 74: 6547–6556.
31. Lee SH, Hava DL, Waldor MK, Camilli A (1999) Regulation and temporal
expression patterns of Vibrio cholerae virulence genes during infection. Cell 99:
625–634.
32. Deutscher J, Francke C, Postma PW (2006) How phosphotransferase system-
related protein phosphorylation regulates carbohydrate metabolism in bacteria.
Microbiol Mol Biol Rev 70: 939–1031.
33. Liang W, Sultan SZ, Silva AJ, Benitez JA (2008) Cyclic AMP post-
transcriptionally regulates the biosynthesis of a major bacterial autoinducer to
modulate the cell density required to activate quorum sensing. FEBS Lett 582:
3744–3750.
34. Ng WL, Bassler BL (2009) Bacterial quorum-sensing network architectures.
Annu Rev Genet 43: 197–222.
35. Zhu J, Miller MB, Vance RE, Dziejman M, Bassler BL, et al. (2002) Quorum-
sensing regulators control virulence gene expression in Vibrio cholerae. Proc Natl
Acad Sci USA 99: 3129–3134.
36. Kovacikova G, Skorupski K (2002) Regulation of virulence gene expression in
Vibrio cholerae by quorum sensing: HapR functions at the aphA promoter. Mol
Microbiol 46: 1135–1147.
37. Ritchie JM, Waldor MK (2009) Vibrio cholerae interactions with the
gastrointestinal tract: lessons from animal studies. Curr Top Microbiol Immunol
337: 37–59.
38. Herrington DA, Hall RH, Losonsky G, Mekalanos JJ, Taylor RK, et al. (1988)
Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio
cholerae pathogenesis in humans. J Exp Med 168: 1487–1492.
39. Peterson KM, Mekalanos JJ (1988) Characterization of the Vibrio cholerae ToxR
regulon: identification of novel genes involved in intestinal colonization. Infect
Immun 56: 2822–2829.
40. Waldor MK, Mekalanos JJ (1994) ToxR regulates virulence gene expression in
non-O1 strains of Vibrio cholerae that cause epidemic cholera. Infect Immun 62:
72–78.
Glucose-Based ORS Extends the Duration of Cholera
PLOS Neglected Tropical Diseases | www.plosntds.org 9 December 2014 | Volume 8 | Issue 12 | e3347
41. Chiang SL, Mekalanos JJ (1998) Use of signature-tagged transposon mutagenesis
to identify Vibrio cholerae genes critical for colonization. Mol Microbiol 27: 797–
805.
42. Childers BM, Klose KE (2007) Regulation of virulence in Vibrio cholerae: the
ToxR regulon. Future Microbiol 2: 335–344.
43. Hung DT, Shakhnovich EA, Pierson E, Mekalanos JJ (2005) Small-molecule
inhibitor of Vibrio cholerae virulence and intestinal colonization. Science 310:
670–674.
44. Shakhnovich EA, Hung DT, Pierson E, Lee K, Mekalanos JJ (2007) Virstatin
inhibits dimerization of the transcriptional activator ToxT. Proc Natl Acad
Sci U S A 104: 2372–2377.
45. Gaudart J, Rebaudet S, Barrais R, Boncy J, Faucher B, et al. (2013) Spatio-
temporal dynamics of cholera during the first year of the epidemic in Haiti.
PLoS Negl Trop Dis 7: e2145.
46. WHO (2002) New formula oral rehydration salts. WHO Drug Information 16:
113–203.
47. Ogierman MA, Voss E, Meaney C, Faast R, Attridge SR, et al. (1996)
Comparison of the promoter proximal regions of the toxin-co-regulated tcp gene
cluster in classical and El Tor strains of Vibrio cholerae O1. Gene 170: 9–16.
48. Skorupski K, Taylor RK (1997) Cyclic AMP and its receptor protein negatively
regulate the coordinate expression of cholera toxin and toxin-coregulated pilus
in Vibrio cholerae. Proc Natl Acad Sci USA 94: 265–270.
49. Liang W, Pascual-Montano A, Silva AJ, Benitez JA (2007) The cyclic AMP
receptor protein modulates quorum sensing, motility and multiple genes that
affect intestinal colonization in Vibrio cholerae. Microbiology 153: 2964–2975.
50. Merrell DS, Butler SM, Qadri F, Dolganov NA, Alam A, et al. (2002) Host-
induced epidemic spread of the cholera bacterium. Nature 417: 642–645.
51. WHO (2005) The treatment of diarrhoea: A manual for physicians and other
senior health workers. Geneva, Switzerland.: WHO Press. 1–44 p.
Glucose-Based ORS Extends the Duration of Cholera
PLOS Neglected Tropical Diseases | www.plosntds.org 10 December 2014 | Volume 8 | Issue 12 | e3347
